Infections in responders with and without LT cytopenia
| No. of infections in responders at time after infusion with tisagenlecleucel . | All grades . | Grade 3 . | Grade 4 . | All grades . | Grade 3 . | Grade 4 . |
|---|---|---|---|---|---|---|
| With LT cytopenia (n = 15) | Without LT cytopenia (n = 28) | |||||
| ≤8 weeks | 5 (33.3) | 1 (6.7) | 0 | 9 (32.1) | 5 (17.9) | 0 |
| With prolonged cytopenia (n = 15) | Without prolonged cytopenia (n = 28) | |||||
| >8 weeks to ≤1 year | 9 (60.0) | 3 (20.0) | 0 | 19 (67.9) | 7 (25.0) | 1 (3.6) |
| (n = 13) | (n = 25) | |||||
| >1 y | 6 (46.2) | 1 (7.7) | 0 | 11 (44.0) | 4 (16.0) | 1 (4.0) |
| No. of infections in responders at time after infusion with tisagenlecleucel . | All grades . | Grade 3 . | Grade 4 . | All grades . | Grade 3 . | Grade 4 . |
|---|---|---|---|---|---|---|
| With LT cytopenia (n = 15) | Without LT cytopenia (n = 28) | |||||
| ≤8 weeks | 5 (33.3) | 1 (6.7) | 0 | 9 (32.1) | 5 (17.9) | 0 |
| With prolonged cytopenia (n = 15) | Without prolonged cytopenia (n = 28) | |||||
| >8 weeks to ≤1 year | 9 (60.0) | 3 (20.0) | 0 | 19 (67.9) | 7 (25.0) | 1 (3.6) |
| (n = 13) | (n = 25) | |||||
| >1 y | 6 (46.2) | 1 (7.7) | 0 | 11 (44.0) | 4 (16.0) | 1 (4.0) |
All data are n (%).